ABSTRACT N-Benzoyladenine-cyanoborane (2), and 6-triphenylphosphonylpurine-cyanoborane (3) were selected for investigation of cytotoxicity in murine and human tumor cell lines, effects on human HL-60 leukemic metabolism and DNA strand scission to determine the feasibility of these compounds as clinical antineoplastic agents. Compounds 2 and 3 both showed effective cytotoxicity based on EDs0 values less than 4 g/ml for L1210, P388, HL-60, Tmolt3, HUT-78, HeLa-S uterine, ileum HCT-8, and liver Hepe-2. Compound 2 had activity against ovary l-A9, while compound 3 was only active against prostate PL and glioma UM. Neither compound was active against the growth of lung 549, breast MCF-7, osteosarcoma HSO, melanoma SK2, KB nasopharynx, and THP-1 acute monocytic leukemia. In mode of action studies in human leukemia HL-60 cells, both compounds demonstrated inhibition of DNA and protein syntheses after 60 min at 100 M. These compounds inhibited RNA synthesis to a lesser extent. The utilization of the DNA template was suppressed by the compounds as determined by inhibition of the activities of DNA polymerase , m-RNA polymerase, r-RNA polymerase and t-RNA polymerase, which would cause adequate inhibition of the synthesis of both DNA and RNA. Both compounds markedly inhibited dihydrofolate reductase activity, especially in compound 2. The compounds appeared to have caused cross-linking of the DNA strands after 24 hr at 100 tM in HL-60 cells, which was consistent with the observed increased in ct-DNA viscosity after 24 hr at 100 tM. The compounds had no inhibitory effects on DNA topoisomerase and II activities or DNA-protein linked breaks. Neither compound interacted with the DNA molecule itself through alkylation of the nucleotide bases nor caused DNA interculation between base pairs. Overall, these antineoplastic agents caused reduction of DNA and protein replication, which would lead to killing of cancer cells.
nucleotides have been reported to be even more potent in suppressing the growth of murine and human cancer cells/2/. A common feature of all of these derivatives was that they effectively suppressed DNA synthesis and the activities of enzymes involved in the nucleic acid metabolism. Selected compounds demonstrated DNA strand scission with inhibition of DNA topoisomerase II activity. Based on these previous studies, NCbenzoyladenine-cyanoborane (2) , 6-triphenyl-phosphonylpurine-cyanoborane (3) were selected for investigation in human leukemia HL-60 cells for cytotoxicity, effects on metabolic events, and DNA strand scission to determine the feasibility of these compounds as clinical antineoplastic agents.
METHODS
The cyanoborane adducts of the substituted purines were prepared via a Lewis acid exchange reaction/9/, by using excess (e.g., 4 molar equivalents) triphenylphosphine-cyanoborane (1) and the amine (purine) in dry dimethylfonnamide (DMF) at 55-70C under nitrogen atmosphere (Scheme 2). In the Lewis acid exchange reaction, a weakly basic or bulky amine or phosphine, as its substituted borane (C6H5)3P.HB r + NaBH3C N Reflux N2(g) (C6H5)3P:BH2CN + HBr + H 2 Scheme 1 Synthesis of the Lewis acid exchange reagent, triphenylphosphine-cyanobomne (1) .
adduct (e.g., Ph3P:BH2CN), is exchanged for a more basic or less bulky amine, (e.g., a substituted purine). These boron exchange reactions must be carried out under anhydrous conditions to avoid coordination of the cyanoborane to water and subsequent degradation to boric acid. The Lewis acid exchange reaction is a general route which has also been used in the preparation of other cyanoborane adducts of aliphatic/3, 9/, aromatic /3,8/, and heterocyclic /8,9/ amines, as well as their borane and carboxyborane adducts /9/. Triphenylphosphine-cyanoborane (_1) was prepared as previously reported/9, 10/(Scheme 1) by refluxing Ph3P HBr and NaBH3CN in dry THF under nitrogen atmosphere. The reaction of 6-chloropurine and triphenylphosphine-cyanoborane produced the unexpected product, 6-triphenylphosphonylpurinecyanoborane (). This resulted when the free triphenylphosphine, formed after the Lewis acid exchange, underwent aromatic nucleophilic substitution displacing the chlorine in the 6 position of the purine ring.
Synthesis of Compounds
All chemicals and reagents were obtained from Aldrich Chemical Company (Milwaukee, WI) and used as received except for dry solvents which were dried and distilled using standard procedures/11/. TLC was performed using silica gel 60F 
Enzyme assays
Studies for the inhibition of various enzyme activities were performed by first preparing the appropriate HL-60 leukemia cell homogenates or subcellular fraction, then adding the drug to be tested during the enzyme assay. For the concentration response studies, inhibition of enzyme activity was determined at 25, 50 and 100 gM of compounds 2 and 3, after 60 rain incubations. DNA polymerase c activity was determined in cytoplasmic isolated extracts [18] . The centrifuged at 600 g X 10 min in PBS. They were later washed and suspended in ml of PBS. Lysis buffer (0.5 ml; 0.5 M NaOH, 0.02 M EDTA, 0.01% Triton X-100 and 2.5% sucrose) was layered onto a 5-20% alkaline-sucrose gradient (5 ml; 0.3 M NaOH, 0.7 KC1 and 0.01 M EDTA); this was followed by 0.2 ml of the cell preparation. After the gradient was incubated for 2.5 hr at room temperature, it was centrifuged at 12,000 RPM at 20C for 60 min (Beckman rotor SW60). Fractions (0.2 ml) were collected from the bottom of the gradient, neutralized with 0.2 ml of 0.3 N HC1, and measured for radioactivity. Thermal Figure 1 ). This was consistent with the increase in ct-DNA viscosity after 24 hr at 100 pM.
Deoxyribonucleotide levels were all slightly reduced after 60 min incubation at 100 laM.
Compound 3 was also examined for its mode of action in HL-60 leukemia cells ( Synthesis and Q,totoxiciv oj'C'yanoborane Adducts Synthesis and C)totoxicit.y of C,yanoborane Adducts 
